Integra LifeSciences (IART)
(Delayed Data from NSDQ)
$12.31 USD
-0.83 (-6.32%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.30 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Integra LifeSciences Holdings Corporation has a market cap of $1.02B, which represents its share price of $13.14 multiplied by its outstanding shares number of 77.71M. As a small-cap company, IART's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IART 12.31 -0.83(-6.32%)
Will IART be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IART
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
IART Stock May Rise on First Enrollment in AERA Pediatric Registry
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?
Other News for IART
Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript
Q2 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript
Integra LifeSciences Reports Q2 2025 Financial Results
Integra LifeSciences (IART) Adjusts FY25 Revenue Guidance
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415. ...